IBDEI24H ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35996,1,3,0)
 ;;=3^Cerebral Infarction d/t Right Posterior Cerebral Artery Occls/Stenosis
 ;;^UTILITY(U,$J,358.3,35996,1,4,0)
 ;;=4^I63.531
 ;;^UTILITY(U,$J,358.3,35996,2)
 ;;=^5007348
 ;;^UTILITY(U,$J,358.3,35997,0)
 ;;=I63.541^^134^1739^10
 ;;^UTILITY(U,$J,358.3,35997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35997,1,3,0)
 ;;=3^Cerebral Infarction d/t Right Cerebellar Artery Occls/Stenosis
 ;;^UTILITY(U,$J,358.3,35997,1,4,0)
 ;;=4^I63.541
 ;;^UTILITY(U,$J,358.3,35997,2)
 ;;=^5007350
 ;;^UTILITY(U,$J,358.3,35998,0)
 ;;=G45.9^^134^1739^23
 ;;^UTILITY(U,$J,358.3,35998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35998,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,35998,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,35998,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,35999,0)
 ;;=Z86.73^^134^1739^16
 ;;^UTILITY(U,$J,358.3,35999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35999,1,3,0)
 ;;=3^Hx of TIA and Cerebral Infarction w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,35999,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,35999,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,36000,0)
 ;;=G82.50^^134^1739^21
 ;;^UTILITY(U,$J,358.3,36000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36000,1,3,0)
 ;;=3^Quadriplegia,Unspec
 ;;^UTILITY(U,$J,358.3,36000,1,4,0)
 ;;=4^G82.50
 ;;^UTILITY(U,$J,358.3,36000,2)
 ;;=^5004128
 ;;^UTILITY(U,$J,358.3,36001,0)
 ;;=R76.11^^134^1740^1
 ;;^UTILITY(U,$J,358.3,36001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36001,1,3,0)
 ;;=3^Abnormal Reaction to Tuberculin Test
 ;;^UTILITY(U,$J,358.3,36001,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,36001,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,36002,0)
 ;;=J47.1^^134^1740^7
 ;;^UTILITY(U,$J,358.3,36002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36002,1,3,0)
 ;;=3^Bronchiectasis w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,36002,1,4,0)
 ;;=4^J47.1
 ;;^UTILITY(U,$J,358.3,36002,2)
 ;;=^5008259
 ;;^UTILITY(U,$J,358.3,36003,0)
 ;;=J47.0^^134^1740^6
 ;;^UTILITY(U,$J,358.3,36003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36003,1,3,0)
 ;;=3^Bronchiectasis w/ Acute Lower Respiratory Infection
 ;;^UTILITY(U,$J,358.3,36003,1,4,0)
 ;;=4^J47.0
 ;;^UTILITY(U,$J,358.3,36003,2)
 ;;=^5008258
 ;;^UTILITY(U,$J,358.3,36004,0)
 ;;=J47.9^^134^1740^8
 ;;^UTILITY(U,$J,358.3,36004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36004,1,3,0)
 ;;=3^Bronchiectasis,Uncomplicated
 ;;^UTILITY(U,$J,358.3,36004,1,4,0)
 ;;=4^J47.9
 ;;^UTILITY(U,$J,358.3,36004,2)
 ;;=^5008260
 ;;^UTILITY(U,$J,358.3,36005,0)
 ;;=J43.2^^134^1740^12
 ;;^UTILITY(U,$J,358.3,36005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36005,1,3,0)
 ;;=3^Centrilobular Emphysema
 ;;^UTILITY(U,$J,358.3,36005,1,4,0)
 ;;=4^J43.2
 ;;^UTILITY(U,$J,358.3,36005,2)
 ;;=^5008237
 ;;^UTILITY(U,$J,358.3,36006,0)
 ;;=J44.1^^134^1740^10
 ;;^UTILITY(U,$J,358.3,36006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36006,1,3,0)
 ;;=3^COPD w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,36006,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,36006,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,36007,0)
 ;;=J44.0^^134^1740^9
 ;;^UTILITY(U,$J,358.3,36007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36007,1,3,0)
 ;;=3^COPD w/ Acute Lower Respiratory Infection
 ;;^UTILITY(U,$J,358.3,36007,1,4,0)
 ;;=4^J44.0
 ;;^UTILITY(U,$J,358.3,36007,2)
 ;;=^5008239
 ;;^UTILITY(U,$J,358.3,36008,0)
 ;;=J44.9^^134^1740^11
 ;;^UTILITY(U,$J,358.3,36008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36008,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,36008,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,36008,2)
 ;;=^5008241
